New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 2 years ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
- Association of Chronic Hepatitis B Infection and Antiviral Treatment With the De
- 1
- 1
- 2 years, 3 months ago
- An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing
- 1
- 1
- 2 years, 3 months ago
- Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Rev
- 1
- 1
- 2 years, 3 months ago
- Comparison of Cholangiocarcinoma and Hepatocellular Carcinoma Incidence Trends f
- 1
- 1
- 2 years, 3 months ago
- Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive bioma
- 1
- 1
- 2 years, 3 months ago
- Current Targeted Therapy Options in the Treatment of Cholangiocarcinoma: A Liter
- 1
- 1
- 2 years, 3 months ago
- Examination on risk factors of cholangiocarcinoma: a Mendelian randomization stu
- 1
- 1
- 2 years, 3 months ago
- Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis
- 1
- 1
- 2 years, 4 months ago
- Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment
- 1
- 1
- 2 years, 4 months ago
- Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication
- 1
- 1
- 2 years, 4 months ago
- Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pa
- 1
- 1
- 2 years, 4 months ago
- The forum ‘New Developments’ is closed to new topics and replies.